Kenneth Cusi

Oct 4, 2024 | healio.com | Michael Monostra |Richard Smith |Kenneth Cusi |Anu Sharma

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Hepatic steatosis was detected among 50.2% of adults younger than 45 years without history of MASLD. Rates of hepatic steatosis and fibrosis were higher among adults with type 2 diabetes and obesity.

Feb 20, 2023 | healio.com | Kenneth Cusi |Heather Biele

Source/Disclosures Source: Healio interviews Disclosures: Cusi reports financial relationships with 89Bio, Altimmune, Arrowhead, AstraZeneca, BMS, Boehringer Ingelheim, Covance, Echosens, Inventiva, Labcorp, Lilly, Madrigal, Merck, Myovant, NIH, Nordic Bioscience, Novo Nordisk, Poxel, Prosciento, Quest, Sagimet, Sonic Incytes, Terns and Zydus.